NeuroGastrX
Home - Neurogastrx, Inc.
United States · $107.8M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- neurogastrx.com
- Total Funding
- $107.8M
- Last Round
- $60.0M Series BAug 2021
- Rounds
- 3
About
Late clinical-stage biopharmaceutical company developing therapies for gastrointestinal disorders and unmet GI patient needs.
Summary
NeuroGastrX is a Biotech company based in United States. It has raised $107.8M in total across 3 rounds, most recently a $60.0M Series B round in Aug 2021. Investors include Vivo Capital, 5AM Ventures and OrbiMed.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company